St. Louis, MO, United States of America

Zhenfu Han

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Zhenfu Han: Innovator in Therapeutic Compounds

Introduction

Zhenfu Han is a prominent inventor based in St. Louis, MO, who has made significant contributions to the field of biochemistry and pharmacology through his innovative work on mitogen-activated protein kinases (MAPKs). With a total of seven patents to his name, Han's research is paving the way for new therapeutic options in the treatment of various diseases.

Latest Patents

Among his latest patents are inclusive of inhibitors targeting mitogen-activated protein kinases. These compounds aim to inhibit specific MAPKs such as MAPK13, as well as multiple MAPKs including both MAPK13 and MAPK12. The therapeutic implications of these compounds are vast, potentially addressing ailments such as cancer and respiratory diseases. Additionally, his patents outline methods for synthesizing these compounds, emphasizing their practical applications in medicinal chemistry.

Career Highlights

Zhenfu Han is affiliated with Washington University, where he has conducted extensive research in the field of therapeutics. His work stands at the intersection of academic inquiry and real-world application, reflecting a commitment to addressing critical health challenges through innovative scientific solutions.

Collaborations

Throughout his career, Han has collaborated with esteemed colleagues, including James Walter Janetka and Scott J. Hultgren. These partnerships highlight the importance of teamwork in advancing scientific research and developing viable therapeutic approaches.

Conclusion

Zhenfu Han exemplifies the spirit of innovation in the scientific community. His contributions in the form of patents not only enhance the understanding of MAPKs but also open new avenues for treating complex diseases. As research continues, Han's work is likely to inspire future innovations in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…